Biocon Pharma recalls
Biocon Pharma has 2 recalls on record with the FDA and USDA, the earliest in 2023 and the latest reported on 9 Apr 2025. 1 is still ongoing. The most frequent reason is potency & assay.
Total recalls2since 2023
Last 12 months0reported
Class I00% of total
Ongoing1latest 9 Apr 2025
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 100%Class III 0 0%
Why biocon pharma is recalled
Product types
Brands
By year
Ongoing biocon pharma recalls
1 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Atorvastatin Calcium Tablets USP 40 mg recalled by Biocon PharmaAtorvastatin Calcium | Biocon Pharma | Potency & Assay | Nationwide |
All biocon pharma recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Atorvastatin Calcium Tablets USP 40 mg recalled by Biocon PharmaAtorvastatin Calcium | Biocon Pharma | Potency & Assay | Nationwide |
| Drug | CLASS II | Posaconazole Delayed-Release Tablets, 100 mg recalled by Biocon PharmaPosaconazole | Biocon Pharma | Potency & Assay | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.